Back

A common plasma lipidomics signature of cardiometabolic and coronary risk in statin users

30 April 2022 (10:50 - 11:30)
Organised by: Logo
Congress Presentation Part of: Moderated poster 9 - Drugs Biomarkers CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2022 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Silvia Rocchiccioli

Institute of Clinical Physiology (IFC), Pisa (Italy)

3 More presentations in this session

Presentation thumbnail
Sex-related differential susceptibility to ponatinib-induced cardiotoxicity and its relationship to modulation of Notch signaling in a murine model
Assistant Professor R. Madonna (Pisa, IT)
Abstract
Presentation thumbnail
ProANP31-67 ameliorates adverse cardiac remodeling and improves systolic and diastolic functions in a preclinical model of cardiorenal syndrome
Professor A. Cataliotti (Oslo, NO)
Abstract
Presentation thumbnail
INZ-701, a recombinant ENPP1-Fc protein, effectively treats and prevents neointimal proliferation in WT and ENPP1 Deficient mice
Doctor F. Rutsch (Munster, DE)
Abstract

Access the full session

Session thumbnail
Moderated poster 9 - Drugs

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2022

30 April 2022 10:50 CET
You may be interested in
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
thumbnail
Congress Presentation
A proteo-genomic discovery approach to identify markers of early heart failure
thumbnail
Congress Session
From genetic signatures to clinical implications

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources